Most recent by Julie Pilitsis, MD, PhD
SPONSORED CONTENT
February 04, 2025
1 min read
Save
FDA approves Onapgo for motor fluctuations in adults with Parkinson’s disease
The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.